Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pramod Kumar Kushawaha
Observed names:
P. K. Kushawaha,
Pramod K Kushawaha,
Pramod K. Kushawaha
Institution:
Central University of Punjab
Observed institutions:
Central University of Punjab,
Central Drug Research Institute,
National Institute of Immunology,
Council of Scientific and Industrial Research
ORCID:
0000-0002-6186-0456
Observed ORCID:
0000-0002-6186-0456
OpenAlex ID:
A5091112687
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Simon I Hay
, Kanyin Liane Ong
, et al.
·
The Lancet
·
1,248
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
2025
·
Austin E Schumacher
, Peng Zheng
, et al.
·
The Lancet
·
280
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Emily Haeuser
, Sam Byrne
, et al.
·
The Lancet
·
193
PDF
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Sarah Brooke Sirota
, Rose Grace Bender
, et al.
·
The Lancet Infectious Diseases
·
162
PDF
Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026
·
Damian F Santomauro
, Paul Anthony Miller
, et al.
·
The Lancet
·
148
PDF
Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis
2009
·
Mukesh Samant
, Reema Gupta
, et al.
·
The Journal of Immunology
·
80
Elongation Factor-2, a Th1 Stimulatory Protein of Leishmania donovani, Generates Strong IFN-γ and IL-12 Response in Cured Leishmania-Infected Patients/Hamsters and Protects Hamsters against Leishmania Challenge
2011
·
Pramod K Kushawaha
, Reema Gupta
, et al.
·
The Journal of Immunology
·
77
PDF
Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease
2023
·
Kavita
, Hari Om
, et al.
·
Microbiological Research
·
63
Staphylococcus aureus vaccine strategy: Promise and challenges
2023
·
Umesh Chand
, Pragnya Priyambada
, et al.
·
Microbiological Research
·
61
Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis
2014
·
Reema Gupta
, Vikash Kumar
, et al.
·
PLoS ONE
·
51
PDF
Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
2012
·
Pramod Kumar Kushawaha
, Reema Gupta
, et al.
·
PLoS ONE
·
50
PDF
Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design
2008
·
Pragya Misra
, Tanvir Khaliq
, et al.
·
Journal of Antimicrobial Chemotherapy
·
47
Th1 Stimulatory Proteins of Leishmania donovani: Comparative Cellular and Protective Responses of rTriose Phosphate Isomerase, rProtein Disulfide Isomerase and rElongation Factor-2 in Combination with rHSP70 against Visceral Leishmaniasis
2014
·
Anil Kumar Jaiswal
, Prashant Khare
, et al.
·
PLoS ONE
·
43
PDF
Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses
2011
·
R. Gupta
, P. K. Kushawaha
, et al.
·
Journal of Antimicrobial Chemotherapy
·
37
Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis
2012
·
Pramod K. Kushawaha
, Reema Gupta
, et al.
·
PLoS ONE
·
34
PDF
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026
·
Avina Vongpradith
, Regina-Mae Villanueva Dominguez
, et al.
·
The Lancet Infectious Diseases
·
30
A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis
2012
·
Reema Gupta
, Pramod K. Kushawaha
, et al.
·
International Journal for Parasitology
·
27
Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026
·
Hyesu Jo
, Tae Hyeon Kim
, et al.
·
The Lancet Respiratory Medicine
·
25
Chandipura Virus Utilizes the Prosurvival Function of RelA NF-κB for Its Propagation
2019
·
Sachendra S. Bais
, Yashika Ratra
, et al.
·
Journal of Virology
·
19
PDF
Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters
2016
·
Chandra Dev Pati Tripathi
, Pramod Kumar Kushawaha
, et al.
·
Phytomedicine
·
18
Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani
2016
·
Sumit Joshi
, Narendra K. Yadav
, et al.
·
Frontiers in Microbiology
·
18
PDF
Human anaerobic microbiome: a promising and innovative tool in cancer prevention and treatment by targeting pyruvate metabolism
2023
·
Hari Om
, Umesh Chand
, et al.
·
Cancer Immunology Immunotherapy
·
17
PDF
Nano-immunomodulators: prospective applications to combat drug resistant bacterial infections and related complications
2023
·
Umesh Chand
, Pramod Kumar Kushawaha
·
Journal of Biomaterials Science Polymer Edition
·
16
Green synthesis of zinc nanoparticles using leaf extract of Clitoria ternatea and evaluation of its antimicrobial and anti-oxidant activity
2025
·
Dibya Rana Saha Roy
, Rukhsar Aman
, et al.
·
The Microbe
·
14
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026
·
Sarah Brooke Sirota
, Rose Grace Bender
, et al.
·
The Lancet Neurology
·
12
Show more works
View as search
Works count:
43
Citation count:
2,852
H-index:
19
I10-index:
29
Year
Topic
Type